Cyclerion Therapeutics Inc (CYCN)

Finanzdaten der Cyclerion Therapeutics Inc-Aktie (CYCN)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	9.86% 1.618	1.795	6.015	4.243	7.042
Operating Income/Loss	9.86% -1.618	-1.795	-6.015	-4.243	-7.042
Nonoperating Income/Loss	24.75% 0.076	0.101	0.107	0.062	0.088
Income/Loss From Continuing Operations Before Tax	127.36% -1.542	5.636	-5.908	-4.181	-6.954
Income/Loss From Continuing Operations After Tax	8.97% -1.542	-1.694	-5.908	-4.181	-6.954
Income/Loss From Discontinued Operations, Net Of Tax	-	-	13.47	-	-
Net Income/Loss	8.97% -1.542	-1.694	7.566	-4.181	-6.954
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	6,295% 2.494	0.039	2.435	2.282	0.0435
Diluted Average Shares	6,295% 2.494	0.039	2.786	2.282	0.0435
Basic Earnings Per Share	11.43% -0.62	-0.70	3.11	-1.83	-0.16
Diluted Earnings Per Share	11.43% -0.62	-0.70	2.72	-1.83	-0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-